Skip to content
Clinical Trials – home

Consorci D'atencio Primaria De Salut Barcelona Esquerra

Research site

Spain Calle De Mejia Lequerica S/n, 08028 Barcelona, Spain

  • 1 trial recruiting
  • Chronic obstructive pulmonary disease · Escherichia urinary tract infection · Influenza
  • Adult patients

About Specializations

Consorci D'atencio Primaria De Salut Barcelona Esquerra in Barcelona, Spain specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Escherichia urinary tract infection, Influenza, Influenza immunisation, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases and Chronic Obstructive Pulmonary Disease

At Consorci D'atencio Primaria De Salut Barcelona Esquerra, research in respiratory medicine focuses on improving day-to-day disease control for people living with Chronic Obstructive Pulmonary Disease. The studies are designed to assess whether newer treatment approaches can offer better symptom stability and overall clinical control than standard care.

  • Evaluating treatment effectiveness in COPD
  • Improving clinical control and symptom stability
  • Comparing established respiratory therapies for high-risk patients

This work reflects a practical focus on helping patients manage chronic breathing problems more effectively in everyday care.

Bacterial Infections and Mycoses with a focus on Invasive Extraintestinal Pathogenic Escherichia coli Disease

The site also contributes to research in infectious diseases, especially studies aimed at preventing serious bacterial illness caused by Escherichia coli. These trials are assessing a vaccine strategy intended to reduce the risk of invasive disease in older adults with a history of urinary tract infection.

  • Prevention of invasive E. coli disease
  • Testing a vaccine approach against key bacterial serotypes
  • Reducing serious bloodstream and sterile-site infections

By focusing on prevention, this research seeks to lower the burden of severe bacterial infections in a vulnerable population.

Virus Diseases and Respiratory Syncytial Virus Infections

Clinical research at this Barcelona site includes studies on respiratory viral infections, particularly respiratory syncytial virus. The trials are designed to evaluate the immune response and safety of vaccination in older adults, with the goal of strengthening protection before seasonal exposure.

  • Assessing immune response to RSV vaccination
  • Supporting prevention of seasonal viral respiratory illness
  • Studying vaccine protection in adults aged 60 years and older

This area of research is especially relevant for improving prevention of respiratory infections that can be more serious in older people.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle De Mejia Lequerica S/n08028 BarcelonaSpain
Recruiting now
1 trial
Conditions studied
9

More sites in BarcelonaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Influenza+1

Recruiting

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years · Healthy volunteers
  • Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
  • Sponsor:GlaxoSmithKline Biologicals

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:GlaxoSmithKline Biologicals

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study of ExPEC9V vaccine for preventing invasive E.

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ECOO15
  • Sponsor:Janssen Vaccines & Prevention B.V.

Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Aclidinium Bromide
  • Sponsor:Fundacio Privada Mon Clinic Barcelona
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.